TMCI$4.37+2.34%
Treace Medical Concepts, Inc.
Sector: Surgical & Medical Instruments & ApparatusIndustry: Medical - DevicesCountry: USExchange: Nasdaq
Mkt Cap:$284.78M
Float & O/S:
Inst Own:
Analysis updated Nov 1, 2026.
Signal8 Summary
TMCI
Unprofitable with short cash runway
Snapshot
Treace Medical sells bunion correction devices with healthy gross margins, but heavy sales spending keeps the company deep in the red.
What's Happening Right Now
- : Treace reported Q2 revenue of $45.4 million, down 4% year-over-year, but raised full-year revenue guidance to $204-$212 million and improved its EBITDA loss outlook.
- : The company announced the first surgical case using its HyperPlate XM Dynamic Compression Locking Implant System, with full commercialization expected in Q3 2026.
